Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Next steps

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Jun 19, 2024 8:23pm

314 Views

Post# 36097058

Next steps

So what I'm hearing from those that dialed in is that the session was nothing really new.

Assuming that all the people who were going to go in on the PP stick with it, they might get to 5m.

And then that 5 m gets you a shelf option. And the shelf option is just a fancy way of saying that they have a big chunk of shares on a shelf ready to put on the market at a moment's notice. Is that a good thing?

Can anyone explain to me why getting a shelf approval is such a win for us as shareholders?

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles